TREATMENT OF OVERACTIVE BLADDER IN OLDER WOMEN INCREASED DOSES OF ANTIMUSCARINIC DRUGS SAFE AND EFFECTIVE ALTERNATIVE TO EXISTING METHODS
The study included 95 female patients of 65 to 74 years (average age 67,1 years), who previously (more than 6 months before this study) took a course of monotherapy with hydrochloride trospium in higher dosages with unstable or weak effect. In this study, all patients were divided into three groups and were treated with two antimuscarinic drugs. The majority of older women suffering from OAB and treatment-resistant taking one antimuscarinic drug in high doses showed a signiﬁcant positive progress in a state by adding a second antimuscarinic agent. The received side effects do not exceed thereof in comparison with treatment with a single drug.